Dynorphin B (1-13) acts as an agonist on opioid κ-receptor.
CAT No: R1332
CAS No:83335-41-5
Synonyms/Alias:Rimorphin;Dynorphin B;83335-41-5;Dynorphin B porcine;Dynorphin B (swine);K41YC3AEI8;RIMORPHIN (OX);DYNORPHIN B (OX);DYNORPHIN B (PIG);DYNORPHIN B (RAT);UNII-K41YC3AEI8;DYNORPHIN B (HUMAN);Dynorphin B (1-13);Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val-Thr;85006-82-2;L-THREONINE, L-TYROSYLGLYCYLGLYCYL-L-PHENYLALANYL-L-LEUCYL-L-ARGINYL-L-ARGINYL-L-GLUTAMINYL-L-PHENYLALANYL-L-LYSYL-L-VALYL-L-VALYL-;Dynorphin B trifluoroacetate salt;DYNORPHIN B-OH;CHEMBL500830;GTPL1622;BDBM85325;AKOS024457470;Dynorphin B porcine, >=95% (HPLC);NCGC00163206-01;NCGC00163206-02;DA-63065;FD108736;H-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val-Thr-OH; H-YGGFLRRQFKVVT-OH;
2. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.